Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
22 Analysts have issued a Qiagen forecast:
22 Analysts have issued a Qiagen forecast:
Dec '24 |
+/-
%
|
||
Revenue | 1,697 1,697 |
1%
1%
|
|
Gross Profit | 1,083 1,083 |
2%
2%
|
|
EBITDA | 433 433 |
11%
11%
|
EBIT (Operating Income) EBIT | 425 425 |
11%
11%
|
Net Profit | 72 72 |
76%
76%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
Head office | United States |
CEO | Thierry Bernard |
Employees | 5,232 |
Founded | 1996 |
Website | www.qiagen.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.